4.5 Article

Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Functions in Older Subjects with Increased CAIDE Dementia Scores

期刊

JOURNAL OF ALZHEIMERS DISEASE
卷 64, 期 1, 页码 71-78

出版社

IOS PRESS
DOI: 10.3233/JAD-180209

关键词

Alzheimer's disease; CAIDE; cognitive decline; cognitive functions; MAPT study; multi-domain intervention; n-3 PUFA; neuropsychological tests; omega-3; prevention

资金

  1. Gerontopole of Toulouse
  2. French Ministry of Health (PHRC)
  3. Pierre Fabre Research Institute (manufacturer of the PUFAs supplement)
  4. Exhonit Therapeutics SA
  5. Avid Radiopharmaceuticals Inc.

向作者/读者索取更多资源

Findings from recent Alzheimer's disease prevention trials have shown subjects with increased dementia score based upon mid-life cardiovascular risk factors, to benefit from multi-domain intervention strategies to some extent. The effects of such interventions on cognitive functions remains yet to be well-established. This study is a secondary analysis of the MAPT study, 1,293 older subjects (mean age 75 years) with high CAIDE score (i.e., >= 6) were classified according to the four intervention groups: 1) multi-domain intervention plus placebo, 2) isolated supplementation with Omega-3 polyunsaturated fatty acid (n-3 PUFA), 3) combination of the two interventions, and 4) placebo alone. Linear mixed-model repeated-measures analyses were used to assess the cognitive changes according to various neuropsychological test scores between intervention groups compared to the placebo at 36 months from baseline. Compared to the placebo, group with multidomain intervention in combination withn-3PUFA was found to show significant improvement in the delayed total recall test of the free and cued selective reminding test (FCSRT) (mean +/- standard error(SE) +/- 0.20 +/- 0.10) and MMSE orientation test (mean +/- SE = 0.15 +/- 0.06) at 36 months. Isolated multi-domain intervention group showed significant less decline in the MMSE orientation test (mean +/- SE = 0.12 +/- 0.06) compared to the placebo. There was significant less improvement (mean +/- SE = -1.01 +/- 0.46) in the FCSRT free recall test in the n-3 PUFA intervention group compared to the placebo at 36 months. Our findings show high-risk subjects for dementia screened with CAIDE dementia score might benefit from multi-domain intervention strategies as in the MAPT study, particularly in the orientation and delayed recall domain.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据